» Articles » PMID: 20535027

Obesity, Metabolic Syndrome, and Microbiota: Multiple Interactions

Overview
Specialty Gastroenterology
Date 2010 Jun 11
PMID 20535027
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

The incredible number and diversity of microorganisms in the human gastrointestinal tract represent a very diverse set of features, which support the host in important functions such as digestion of complex carbohydrates. Conventionalization of germ-free mice with a normal gut microbiota harvested from the intestine of conventionally raised mice results in weight gain and obesity. Development of obesity in genetically or diet-induced obese mice is associated with dramatic changes in the composition and metabolic function of the microbiota. This trait is transmissible as colonization of germ-free mice with an "obese-gut-derived" microflora results in a much greater increase in total body fat and leads to obesity. The first studies in obese and lean twins suggest that a core gut microbiome exists, and that obese individuals exhibit reduced diversity and an altered representation of metabolic pathways in their microbiota. Diet may have a fundamental effect on the composition of our microbiota. Early studies highlight the importance for specific diets such as a high-fat diet, which efficiently and very rapidly (within a single day) modulates the gut microbiome. The innate immune system might influence the metabolic syndrome and obesity, as mice deficient in Toll-like receptor 5 develop hyperphagia, become obese and insulin resistant. Importantly, transmission of the microbiota from these mice to healthy mice results in features of the metabolic syndrome. Available data suggest that the microbiota might play a role in the development of metabolic syndrome and obesity.

Citing Articles

Deciphering the role of female reproductive tract microbiome in reproductive health: a review.

Gao H, Liu Q, Wang X, Li T, Li H, Li G Front Cell Infect Microbiol. 2024; 14:1351540.

PMID: 38562966 PMC: 10982509. DOI: 10.3389/fcimb.2024.1351540.


Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.

Bahitham W, Alghamdi S, Omer I, Alsudais A, Hakeem I, Alghamdi A Biomedicines. 2024; 12(3).

PMID: 38540163 PMC: 10967987. DOI: 10.3390/biomedicines12030550.


Bile Acids and Short-Chain Fatty Acids Are Modulated after Onion and Apple Consumption in Obese Zucker Rats.

Balderas C, de Ancos B, Sanchez-Moreno C Nutrients. 2023; 15(13).

PMID: 37447361 PMC: 10347221. DOI: 10.3390/nu15133035.


The Antioxidant Effect of Dietary Bioactives Arises from the Interplay between the Physiology of the Host and the Gut Microbiota: Involvement of Short-Chain Fatty Acids.

Cuciniello R, Di Meo F, Filosa S, Crispi S, Bergamo P Antioxidants (Basel). 2023; 12(5).

PMID: 37237938 PMC: 10215132. DOI: 10.3390/antiox12051073.


Does Multi-Strain Probiotic Supplementation Impact the Effort Capacity of Competitive Road Cyclists?.

Mazur-Kurach P, Fraczek B, Klimek A Int J Environ Res Public Health. 2022; 19(19).

PMID: 36231510 PMC: 9566127. DOI: 10.3390/ijerph191912205.